Synapse - Howard Scher

Results (29)

Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq

Meeting Abstract

Cabel, L.; An, J. A. R.; Kurtz, D.; Ross, D.; Dikoglu, E.; Chen, Y.; Murphy, K.; Szuhany, K.; Stowell, S. L.; Maloney, D.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Automated real-world data integration improves cancer outcome prediction

Journal Article

Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
Nature (2024)

Fulltext@MSK | Save

Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer

Journal Article

Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC

Meeting Abstract

Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

Journal Article

Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies

Journal Article

Zaidi, S.; Park, J.; Chan, J. M.; Roudier, M. P.; Zhao, J. L.; Gopalan, A.; Wadosky, K. M.; Patel, R. A.; Sayar, E.; Karthaus, W. R.; more...
Proceedings of the National Academy of Sciences of the United States of America (2024)

Fulltext@MSK | Save

Impact of PARP inhibitor and platinum therapy on clonal hematopoiesis

Meeting Abstract

Baeten, J. T.; Chan, I. C. C.; Moukarzel, L.; Carter, A. C.; Patel, M.; Stopsack, K. H.; Pharoah, P.; Brenton, J.; Li, B. T.; Abida, W.; more...
Blood (2023)

Fulltext@MSK | Save

Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)

Meeting Abstract

Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Analysis of BRCA2 copy number loss and genomic instability in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

Journal Article

Barnett, E. S.; Schultz, N.; Stopsack, K. H.; Lam, E. T.; Arfe, A.; Lee, J.; Zhao, J. L.; Schonhoft, J. D.; Carbone, E. A.; Keegan, N. M.; more...
European Urology (2023)

Fulltext@MSK | Save

Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer

Journal Article

Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
European Urology (2023)

Fulltext@MSK | Save